Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Dermatology
Charles J. Dimitroff has not added Biography.
If you are Charles J. Dimitroff and would like to personalize this page please email our Author Liaison for assistance.
Direct real-time observation of E- and P-selectin-mediated rolling on cutaneous lymphocyte-associated antigen immobilized on Western blots.
Journal of immunology (Baltimore, Md. : 1950) Jun, 2002 | Pubmed ID: 12023362
Glycosylation-dependent inhibition of cutaneous lymphocyte-associated antigen expression: implications in modulating lymphocyte migration to skin.
Blood Jan, 2003 | Pubmed ID: 12393521
Prevention of leukocyte migration to inflamed skin with a novel fluorosugar modifier of cutaneous lymphocyte-associated antigen.
The Journal of clinical investigation Oct, 2003 | Pubmed ID: 14523038
Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin.
Cancer research Aug, 2004 | Pubmed ID: 15289332
Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cells.
Cancer research Jul, 2005 | Pubmed ID: 15994950
Ameliorating skin-homing receptors on malignant T cells with a fluorosugar analog of N-acetylglucosamine: P-selectin ligand is a more sensitive target than E-selectin ligand.
The Journal of investigative dermatology Sep, 2006 | Pubmed ID: 16691194
The 130-kDa glycoform of CD43 functions as an E-selectin ligand for activated Th1 cells in vitro and in delayed-type hypersensitivity reactions in vivo.
The Journal of investigative dermatology Aug, 2007 | Pubmed ID: 17392823
Vitamins A and D are potent inhibitors of cutaneous lymphocyte-associated antigen expression.
The Journal of allergy and clinical immunology Jan, 2008 | Pubmed ID: 17910894
Targeting selectins and selectin ligands in inflammation and cancer.
Expert opinion on therapeutic targets Nov, 2007 | Pubmed ID: 18028011
Skin-homing receptors on effector leukocytes are differentially sensitive to glyco-metabolic antagonism in allergic contact dermatitis.
Journal of immunology (Baltimore, Md. : 1950) Dec, 2007 | Pubmed ID: 18056398
Analysis of glycosyltransferase expression in metastatic prostate cancer cells capable of rolling activity on microvascular endothelial (E)-selectin.
Glycobiology Oct, 2008 | Pubmed ID: 18647941
Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking.
Proceedings of the National Academy of Sciences of the United States of America Nov, 2009 | Pubmed ID: 19889975
Development of a nascent galectin-1 chimeric molecule for studying the role of leukocyte galectin-1 ligands and immune disease modulation.
Journal of immunology (Baltimore, Md. : 1950) Oct, 2010 | Pubmed ID: 20844192
Peracetylated 4-fluoro-glucosamine reduces the content and repertoire of N- and O-glycans without direct incorporation.
The Journal of biological chemistry Jun, 2011 | Pubmed ID: 21493714
Galectin-1 research in T cell immunity: Past, present and future.
Clinical immunology (Orlando, Fla.) Feb, 2012 | Pubmed ID: 22019770
Metabolic inhibition of galectin-1-binding carbohydrates accentuates antitumor immunity.
The Journal of investigative dermatology Feb, 2012 | Pubmed ID: 22158550
Evidence of a novel galectin-9-binding membrane glycoprotein ligand on T helper cells.
Clinical immunology (Orlando, Fla.) Jan, 2012 | Pubmed ID: 22321867
Brigham and Women's Hospital and Harvard Medical School
Brigham and Women's Hospital, Harvard Medical School
Georg Wiese1,
Steven R. Barthel2,
Charles J. Dimitroff2
1Department of Dermatology, Brigham and Women's Hospital,
2Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School
Monica M. Burdick1,2,
Nathan M. Reynolds1,2,
Eric W. Martin2,
Jacquelyn V. Hawes1,
Grady E. Carlson1,
Chaz M. Cuckler1,
Michael C. Bates1,
Steven R. Barthel3,
Charles J. Dimitroff3
1Department of Chemical and Biomolecular Engineering, Ohio University,
2Biomedical Engineering Program, Russ College of Engineering and Technology, Ohio University,
3Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.